Ovid Therapeutics Statistics
Total Valuation
OVID has a market cap or net worth of $415.21 million. The enterprise value is $266.14 million.
Important Dates
The last earnings date was Tuesday, November 10, 2026, before market open.
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OVID has 188.73 million shares outstanding. The number of shares has increased by 117.58% in one year.
| Current Share Class | 188.73M |
| Shares Outstanding | 188.73M |
| Shares Change (YoY) | +117.58% |
| Shares Change (QoQ) | +2.82% |
| Owned by Insiders (%) | 2.26% |
| Owned by Institutions (%) | 79.37% |
| Float | 167.32M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 285.76 |
| Forward PS | 3,139.11 |
| PB Ratio | 2.09 |
| P/TBV Ratio | 2.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 183.17 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.97, with a Debt / Equity ratio of 0.06.
| Current Ratio | 11.97 |
| Quick Ratio | 11.52 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -35.43% and return on invested capital (ROIC) is -127.14%.
| Return on Equity (ROE) | -35.43% |
| Return on Assets (ROA) | -29.95% |
| Return on Invested Capital (ROIC) | -127.14% |
| Return on Capital Employed (ROCE) | -32.42% |
| Weighted Average Cost of Capital (WACC) | 5.42% |
| Revenue Per Employee | $63,174 |
| Profits Per Employee | -$1.86M |
| Employee Count | 23 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +71.88% in the last 52 weeks. The beta is 0.24, so OVID's price volatility has been lower than the market average.
| Beta (5Y) | 0.24 |
| 52-Week Price Change | +71.88% |
| 50-Day Moving Average | 2.46 |
| 200-Day Moving Average | 2.43 |
| Relative Strength Index (RSI) | 40.73 |
| Average Volume (20 Days) | 2,559,295 |
Short Selling Information
The latest short interest is 18.13 million, so 9.61% of the outstanding shares have been sold short.
| Short Interest | 18.13M |
| Short Previous Month | 18.07M |
| Short % of Shares Out | 9.61% |
| Short % of Float | 10.84% |
| Short Ratio (days to cover) | 9.91 |
Income Statement
In the last 12 months, OVID had revenue of $1.45 million and -$42.84 million in losses. Loss per share was -$0.28.
| Revenue | 1.45M |
| Gross Profit | 1.45M |
| Operating Income | -68.20M |
| Pretax Income | -43.11M |
| Net Income | -42.84M |
| EBITDA | -68.12M |
| EBIT | -68.20M |
| Loss Per Share | -$0.28 |
Full Income Statement Balance Sheet
The company has $161.42 million in cash and investments and $12.35 million in debt, with a net cash position of $149.07 million or $0.79 per share.
| Cash & Investments | 161.42M |
| Total Debt | 12.35M |
| Net Cash | 149.07M |
| Net Cash Per Share | $0.79 |
| Equity (Book Value) | 198.67M |
| Book Value Per Share | 1.05 |
| Working Capital | 130.10M |
Full Balance Sheet Cash Flow
| Operating Cash Flow | -57.78M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 83,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -57.78M |
| FCF Per Share | -$0.31 |
Full Cash Flow Statement Margins
| Gross Margin | 100.00% |
| Operating Margin | -4,693.74% |
| Pretax Margin | -2,967.24% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OVID does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -117.58% |
| Shareholder Yield | -117.58% |
| Earnings Yield | -12.59% |
| FCF Yield | -13.92% |
Analyst Forecast
The average price target for OVID is $6.15, which is 179.55% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.15 |
| Price Target Difference | 179.55% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | -67.29% |
| EPS Growth Forecast (3Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
| Graham Formula Value | n/a |
| Graham Formula Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OVID has an Altman Z-Score of 5.64 and a Piotroski F-Score of 1.
| Altman Z-Score | 5.64 |
| Piotroski F-Score | 1 |